What is Emergent Biosolutions's current ratio?

Emergent Biosolutions (EBS) reported current ratio of 4.3× in Q1 2026.

How has Emergent Biosolutions's current ratio changed year-over-year?

Emergent Biosolutions's current ratio decreased by 32.1% year-over-year, from 6.3× to 4.3×.

What is the long-term trend for Emergent Biosolutions's current ratio?

Over 5 years (2020 to 2025), Emergent Biosolutions's current ratio has grown at a 10.0% compound annual growth rate (CAGR), from 3.1× to 5×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Emergent Biosolutions EBS Current ratio

Current ratio at other companies

Thermo Fisher ScientificTMO

1.5×-0.2×

Regeneron PharmaceuticalsREGN

3.6×-1.4×

AMP

Amphastar PharmaceuticalsAMPH

3.9×+0.9×

Amneal Pharmaceuticals, Inc.AMRX

2.5×+1.1×

CorMedixCRMD

3×-1.2×

Collegium Pharmaceutical, Inc.COLL

1.7×+0.6×

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

total current assets/total current liabilities=4.3×

Based on the most recent quarter.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's current ratio?: Emergent Biosolutions (EBS) reported current ratio of 4.3× in Q1 2026.
How has Emergent Biosolutions's current ratio changed year-over-year?: Emergent Biosolutions's current ratio decreased by 32.1% year-over-year, from 6.3× to 4.3×.
What is the long-term trend for Emergent Biosolutions's current ratio?: Over 5 years (2020 to 2025), Emergent Biosolutions's current ratio has grown at a 10.0% compound annual growth rate (CAGR), from 3.1× to 5×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.